Doctorly

About Doctorly

Doctorly GmbH, a Berlin-based health-tech firm, is addressing the technological gap in German medical practices by replacing outdated administrative software. Founded in 2017 by a team including CEO Samir El-Alami, COO Nicklas Teicke, Anna Von Stackelberg, and Chief Medical Officer Dr. Archil Eristavi, the company targets an inefficiency problem, noting that much of the existing software dates back to the 1980s and 90s. After an intensive multi-year research and development phase to meet Germany's stringent regulatory requirements, Doctorly launched its product in early 2022.

The founding team combines diverse expertise. Samir El-Alami has a background in marketing and has held leadership roles at several high-growth startups across fintech, insurtech, and health-tech. Nicklas Teicke brings experience from the e-commerce sector and in scaling agile companies. Dr. Archil Eristavi, a neurosurgeon with over 15 years of experience, including nine years in London's NHS and private hospitals, provides deep medical insight. This blend of tech entrepreneurship and medical expertise underpins the company's approach. The founders identified that while many patient-facing health apps existed, they lacked integration with the core systems used by doctors, highlighting a critical bottleneck in the healthcare system.

Doctorly provides a cloud-based practice management platform as a Software-as-a-Service (SaaS) solution for medical practices such as general practitioners, urologists, and gynecologists. The platform aims to streamline administrative tasks, potentially reducing the time spent on them by up to 50%. Its features include electronic health records (EHR), appointment scheduling, prescription management, billing and invoicing, and secure communication tools. By being cloud-based, it allows medical records to be more easily accessed by different stakeholders involved in a patient's care. The business model operates on a B2B2C basis, providing doctors with digital tools to manage their practice and engage with patients, while also enabling patients to access their health records through a planned patient app.

The company has successfully navigated multiple funding rounds, securing a total of $22.8 million. Key rounds include a $5.6 million seed round in June 2020 and a two-part Series A round, which raised $10 million in March 2023 and a $7.2 million extension in November 2023. Notable investors include Horizons Ventures, Speedinvest, UNIQA Ventures, and Canadian healthcare company WELL Health Technologies. These funds are earmarked for expanding the sales and marketing teams and accelerating growth within the German market, with long-term plans for European expansion.